Starting and staying on preventive medication for cardiovascular disease

Current Opinion in Cardiology

Volumn 27, Issue 5, 2012, Pages 533-541

  Gale, Nicola ^a   Marshall, Tom ^a   Bramley, George ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

decision making; preferences; prevention; qualitative; service design

Indexed keywords

CARDIOVASCULAR DISEASE; HEALTH CARE PERSONNEL; HEALTH CARE PRACTICE; HUMAN; MEDICAL RESEARCH; MEDLINE; NUMBERS NEEDED TO TREAT; PREVENTION STUDY; PRIORITY JOURNAL; PSYCINFO; PUBLIC HEALTH PROBLEM; QUALITATIVE RESEARCH; REVIEW; SMOKING; TRANSLATIONAL RESEARCH;

CARDIOVASCULAR DISEASES; DECISION MAKING; HEALTH PERSONNEL; HUMANS; MEDICATION ADHERENCE; PREVENTIVE MEDICINE; QUALITATIVE RESEARCH; RESEARCH DESIGN;

EID: 84865499193     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328356dae5     Document Type: Review

References (37)

1. Cooksey D. A review of UK health research funding. HMSO; 2006. http:// www.hm-treasury.gov.uk/d/pbr06-cooksey-final-report-636.pdf. [Accessed4 May 2012]
2. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo controlled trial. Lancet 2002; 360:7-22.
3. Pedersen TR, Berg K, Cook TJ, et al. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Int Med 1996; 156:2085-2092. (Pubitemid 26346967)
4. Ward S, Lloyd Jones M, Pandor A, Holmes M, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess 2007; 11:1-160.
5. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of CVD: meta-analysis of 147 randomised trials in the context of expectation from prospective epidemiological studies. BMJ 2009; 338:b1665.
6. National Cholesterol Education Program (NCEP). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
7. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Institutes of Health, National Heart, Lung and Blood Institute, National High Blood Pressure Education Program. NIH Publication No. 03-5233; May 2003.
8. Anderson KM, Odell PM, Silson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121:293-298.
9. Steel N. Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey. BMJ 2000; 320:1446-1447. (Pubitemid 30311676)
10. McAlister FA, Laupacis A, Teo KK, et al. A survey of clinician attitudes and management practices in hypertension. J Hum Hypertens 1997; 11:413-419. (Pubitemid 27389170)
11. Lewis DK, Barton S. Who decides when to start preventive treatment? A questionnaire survey to compare the views of different population subgroups. J Epidemiol Community Health 2003; 57:241-242. (Pubitemid 36399109)
12. Trewby PN, Reddy AV, Trewby CS, et al. Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs. Clin Med 2002; 2:527-533. (Pubitemid 35477318)
13. Llewellyn-Thomas HA, Paterson M, Carter JA, et al. Primary prevention drug therapy: can it meet patients' requirements for reduced risk? Med Decis Making 2002; 22:326-339. (Pubitemid 34791320)
14. Bryan S, Gill P, Greenfield S, et al. Predictors of patients' preferences for treatments to prevent heart disease. Heart 2006; 92:1651-1655. (Pubitemid 44629179)
15. Bryan S, Gill P, Greenfield S, et al. Clinicians' preferences for treatments to prevent heart disease: a postal survey. Heart 2005; 91:377-378. (Pubitemid 40299230)
16. Bryan S, Gill P, Greenfield S, et al. The myth of agency and patient choice in healthcare? The case of drug treatments to prevent coronary disease. Social Sci Med 2006; 63:2698-2701. (Pubitemid 44485283)
17. Gale N, Greenfield S, Gill P, et al. Patient and general practitioner attitudes to taking medication to prevent cardiovascular disease after receiving detailed information on risks and benefits of treatment: a qualitative study. BMC Fam Pract 2011; 12:59. doi: 10.1186/1471-2296-12-59.
18. Cranney M, Warren E, Walley T. Hypertension in the elderly: attitudes of British patients and general practitioners. J Hum Hypertens 1998; 12:539-545. (Pubitemid 28430223)
19. Frijling BD, Lobo CM, Keus IM, et al. Perceptions of cardiovascular risk among patients with hypertension or diabetes. Patient Educ Couns 2004; 52:47-53. (Pubitemid 38083167)
20. Tang JL, Wang WZ, An JG, et al. How willing are the public to pay for antihypertensive drugs for primary prevention of cardiovascular disease: a survey in a Chinese city. Int J Epidemiol 2010; 39:244-254.
21. Montgomery AA, Harding J, Fahey T. Shared decision making in hypertension: the impact of patient preferences on treatment choice. Fam Pract 2001; 18:309-313. (Pubitemid 32514687)
22. Nobbit GW, Hare RD. Meta-ethnography: synthesizing qualitative studies. Newbury Park, CA: Sage; 1988.
23. Pearson M, Moxham T, Ashton K. Effectiveness of search strategies for qualitative research about barriers and facilitators of program delivery. Eval Health Prof 2011; 34:297-308.
24. Daly J, Willis K, Small R, et al. A hierarchy of evidence for assessing qualitative health research. J Clin Epidemiol 2007; 60:43-49. (Pubitemid 44856239)
25. Critical Appraisal Skills Programme (CASP). Making sense of evidence 10 questions to help you make sense of qualitative research. Access at http://www.sph.nhs.uk/sph-files/casp-appraisal-tools/ Qualitative%20Appraisal%20Tool.pdf. [Accessed 1 May 2012]
26. Shaw RL. Identifying and synthesizing qualitative literature. In: Harper D, Thompson A, editors. Qualitative methods in mental health and psychotherapy: an introduction for students and practitioners. Chapter 2. Oxford: Wiley; 2011.
27. Popay J, Rogers A, Williams G. Rationale and standards for the systematic review of qualitative literature in health services research. Qual Health Res 1998; 8:341-351. (Pubitemid 128624442)
28. Fairhurst K, Huby G. From trial data to practical knowledge: qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia. BMJ 1998; 317:1130-1134. (Pubitemid 28477392)
29. Summerskill WSM, Pope C. 'I saw the panic rise in her eyes, and evidencebased medicine went out of the door.' An exploratory qualitative study of barriers to secondary prevention in management of coronary heart disease. Fam Pract 2002; 19:605-610. (Pubitemid 35460643)
30. Van Steenkiste B, van der Weijden T, Stoffers HE, Grol R. Barriers to implementing cardiovascular risk tables in routine general practice. Scand J Prim Healthcare 2004; 22:32-37. (Pubitemid 38477888)
31. Lewis DK, Robinson J, Wilkinson E. Factors involved in deciding to start preventive treatment: qualitative study of clinicians' and lay people's attitudes. BMJ 2003; 327:841.
32. Hill S, Spink J, Cadilhac D, et al. Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of healthcare consumers and general practitioners involved in a focus group study. BMC Public Health 2010; 10:108.
33. Harkins C, Shaw R, Gillies M, et al. Overcoming barriers to engaging socioeconomically disadvantaged populations in CHD primary prevention: a qualitative study. BMC Public Health 2010; 10:391. http://www.biomedcentral. com/1471-2458/10/391.
34. Goldman RE, Parker DR, Eaton CB, et al. Patients' perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies. Ann Fam Med 2006; 4:205-212. doi: 10.1370/afm.534. (Pubitemid 43824793)
35. Bryant LL, Chin NP, Cottrell LA, et al. Perceptions of cardiovascular health in underserved communities. Prev Chronic Dis 2010; 7. http://www.cdc.gov/pcd/issues/2010/mar/09-0004.htm. [Accessed 6 February 2012]
36. Swanlund SL. Successful cardiovascular medication management processes as perceived by community-dwelling adults over age 74. Appl Nurs Res 2010; 23:22-29.
37. Saukko PM, Farrimond H, Evans PH, Nadeem Qureshi N. Beyond beliefs: risk assessment technologies shaping patients' experiences of heart disease prevention. Sociol Health Illn 2011; 34:560-575.